People · Operator
Named in public records as an officer, director or promoter · active 2012–2024 · Biotechnology, Biotech, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NABsys Inc | — | Biotechnology | Series B | $70.3M | $1.0B | 2014 |
| Transplant Genomics Inc. | — | Biotech | Series A | $20.6M | $288.4M | 2016 |
| Replicel Life Sciences Inc. | — | Other Technology | Pre-Seed | $5.5M | $867K | 2017 |
| 901 Holdings, LLC | — | Other | Seed | $2.2M | $40.9M | 2012 |
Peter Lewis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Lewis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Martirano | 1 | 11 |
| DAVID HALL | 1 | 8 |
| Ray Stata | 1 | 7 |
| Leroy Hood | 1 | 5 |
| Jay Venkatesan | 1 | 5 |
| Geoff MacKay | 1 | 5 |
| Stanley Rose | 1 | 4 |
| Darren Lee | 1 | 3 |
| PETER JENSEN | 1 | 3 |
| DANIEL SOLOMON | 1 | 3 |
| Stan Rose | 1 | 3 |
| Lionel Carnot | 1 | 3 |
| William Gerber | 1 | 3 |
| Gina Raimondo | 1 | 2 |
| TOM KORDYBACK | 1 | 2 |
| John Oliver | 1 | 2 |
| TOM RICHARD KORDYBACK | 1 | 1 |
| JOHN RICHARD CHALLIS | 1 | 1 |
| Michael Abecassis | 1 | 1 |
| Daniel Salomon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.